9ETO

PsiK from Psilocybe cubensis


Experimental Data Snapshot

  • Method: X-RAY DIFFRACTION
  • Resolution: 2.54 Å
  • R-Value Free: 0.243 
  • R-Value Work: 0.197 

Starting Model: in silico
View more details

wwPDB Validation   3D Report Full Report


Ligand Structure Quality Assessment 


This is version 1.0 of the entry. See complete history


Literature

Substrate recognition by the 4-hydroxytryptamine kinase PsiK in psilocybin biosynthesis.

Rogge, K.Wagner, T.J.Hoffmeister, D.Rupp, B.Werten, S.

(2024) FEBS Lett 

  • DOI: https://doi.org/10.1002/1873-3468.15042
  • Primary Citation of Related Structures:  
    9ETO

  • PubMed Abstract: 

    Psilocybin, the natural hallucinogen from Psilocybe (magic) mushrooms, is a highly promising drug candidate for the treatment of depression and several other mental health conditions. Biosynthesis of psilocybin from the amino acid l-tryptophan involves four strictly sequential modifications. The third of these, ATP-dependent phosphorylation of the intermediate 4-hydroxytryptamine, is catalysed by PsiK. Here we present a crystallographic analysis and a structure-based mutagenesis study of this kinase, providing insight into its mode of substrate recognition. The results of our work will support future bioengineering efforts aimed at generating variants of psilocybin with enhanced therapeutic properties.


  • Organizational Affiliation

    Institute of Pharmacy, Friedrich Schiller University, Jena, Germany.


Macromolecules
Find similar proteins by:  (by identity cutoff)  |  3D Structure
Entity ID: 1
MoleculeChains Sequence LengthOrganismDetailsImage
4-hydroxytryptamine kinase
A, B
364Psilocybe cubensisMutation(s): 0 
Gene Names: psiK
EC: 2.7.1 (PDB Primary Data), 2.7.1.222 (PDB Primary Data)
UniProt
Find proteins for P0DPA8 (Psilocybe cubensis)
Explore P0DPA8 
Go to UniProtKB:  P0DPA8
Entity Groups  
Sequence Clusters30% Identity50% Identity70% Identity90% Identity95% Identity100% Identity
UniProt GroupP0DPA8
Sequence Annotations
Expand
  • Reference Sequence
Small Molecules
Ligands 4 Unique
IDChains Name / Formula / InChI Key2D Diagram3D Interactions
RWB
Query on RWB

Download Ideal Coordinates CCD File 
L [auth A]dodecaethylene glycol monomethyl ether
C25 H52 O13
PLQZJIIDLZRWBG-UHFFFAOYSA-N
PEG (Subject of Investigation/LOI)
Query on PEG

Download Ideal Coordinates CCD File 
C [auth A],
M [auth B]
DI(HYDROXYETHYL)ETHER
C4 H10 O3
MTHSVFCYNBDYFN-UHFFFAOYSA-N
SO4
Query on SO4

Download Ideal Coordinates CCD File 
D [auth A]
E [auth A]
F [auth A]
G [auth A]
K [auth A]
D [auth A],
E [auth A],
F [auth A],
G [auth A],
K [auth A],
N [auth B],
O [auth B],
P [auth B],
Q [auth B],
R [auth B]
SULFATE ION
O4 S
QAOWNCQODCNURD-UHFFFAOYSA-L
CL
Query on CL

Download Ideal Coordinates CCD File 
H [auth A],
I [auth A],
J [auth A],
S [auth B],
T [auth B]
CHLORIDE ION
Cl
VEXZGXHMUGYJMC-UHFFFAOYSA-M
Experimental Data & Validation

Experimental Data

  • Method: X-RAY DIFFRACTION
  • Resolution: 2.54 Å
  • R-Value Free: 0.243 
  • R-Value Work: 0.197 
  • Space Group: C 1 2 1
Unit Cell:
Length ( Å )Angle ( ˚ )
a = 111.82α = 90
b = 70.14β = 95.837
c = 118.9γ = 90
Software Package:
Software NamePurpose
REFMACrefinement
XDSdata reduction
XSCALEdata scaling
PHASERphasing

Structure Validation

View Full Validation Report



Ligand Structure Quality Assessment 


Entry History & Funding Information

Deposition Data


Funding OrganizationLocationGrant Number
Austrian Science FundAustriaI-5192

Revision History  (Full details and data files)

  • Version 1.0: 2024-11-06
    Type: Initial release